期刊
MOVEMENT DISORDERS
卷 31, 期 8, 页码 1226-1230出版社
WILEY-BLACKWELL
DOI: 10.1002/mds.26615
关键词
Parkinson's disease; alpha-synuclein; penetrance; asymptomatic; A53T
资金
- MEFOPA grant [FP7-HEALTH-241791]
BackgroundG209A SNCA mutation carriers represent an important group of genetic PD. We describe motor and nonmotor features of G209A SNCA mutation carriers. MethodsLongitudinal clinical assessments over 2 years were collected in 22 symptomatic and 8 asymptomatic G209A SNCA mutation carriers. Motor and nonmotor rating scales were administered. Correlations were performed between clinical variables and disease duration or age. Penetrance was calculated using Kaplan-Meier survival curves. ResultsAsymptomatic carriers did not manifest clear premotor symptoms, but symptomatic carriers often reported that olfactory dysfunction and rapid eye movement sleep behavior disorder preceded motor symptoms. Prominent motor decline and deterioration of autonomic and cognitive function occurred at follow-up; such nonmotor features correlated with disease duration, but not age. Disease penetrance was estimated at around 90%. ConclusionsThis study may help to inform clinical trials and provide the basis for studies of disease modifiers in genetic synucleinopathy cohorts. (c) 2016 International Parkinson and Movement Disorder Society
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据